Trial · NCT07911111
Acceptance and Commitment Therapy in Adolescents With Emotional Difficulties
NCT07911111, Not applicable, Completed, Juan Miguel Flujas
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Acceptance and Commitment Therapy in Adolescents With Emotional Difficulties. Trials, record NCT07911111. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07911111
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Acceptance and Commitment Therapy in Adolescents With Emotional Difficulties
- NCT number
- NCT07911111
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 6 participants, actual
- Lead sponsor
- Juan Miguel Flujas
- Conditions
- Emotional Difficulties
- Interventions
- An intervention protocol based on Acceptance and Commitment Therapy (ACT)
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The Difficulties in Emotion Regulation Scale (DERS; Gómez-Simón et al., 2014) | Change from baseline immediately after the intervention | It is a 36-item scale designed to assess emotion regulation strategies. It comprises six subscales: awareness, impulse control, non-acceptance, goal-directed behavior, emotional clarity, and access to emotion regulation strategies. Cronbach's alpha ranged from .62 to .88 |
| Primary | The Avoidance and Fusion Questionnaire for Youth (AFQ-Y; Valdivia-Salas et al., 2016) | Change from baseline immediately after the intervention | It consists of 17 items comprising two factors: experiential avoidance and cognitive fusion (core processes of psychological inflexibility). Cronbach's alpha ranged from .76 to .87 |
| Primary | The Willingness and Action Measure for Children and Adolescents (WAM-C/A; Cobos-Sánchez et al., 2020) | Change from baseline immediately after the intervention | It consists of 14 items and assesses psychological flexibility through two subscales: willingness to remain in contact with unpleasant experiences and values-based action. Cronbach's alpha ranged from .72 to .81 |
| Primary | The Committed Action Questionnaire (CAQ-8; Escoz-Rodríguez et al., in press) in its 8-item version | Change from baseline immediately after the intervention | Assesses the positive and negative aspects of committed action, defined as an individual's willingness to persist in goal-directed behavior. Cronbach's alpha ranged from .69 to .80 |
| Primary | The Overall Anxiety Severity and Impairment Scale (OASIS; Osma et al., 2022) | Change from baseline immediately after the intervention | It is a five-item unidimensional scale designed to assess the severity of anxiety symptoms and associated functional impairment in specific situations or as a state measure. Cronbach's alpha was .94 |
| Primary | The Overall Depression Severity and Impairment Scale (ODSIS; Osma et al., 2022) | Change from baseline immediately after the intervention | It is a five-item unidimensional scale designed to assess the severity of depressive symptoms and associated functional impairment as a state or in specific situations. Cronbach's alpha was .95 |
| Secondary | The Overall Anxiety Severity and Impairment Scale (OASIS; Osma et al., 2022) | Pre-session assessment (sessions 2-10) | It is a five-item unidimensional scale designed to assess the severity of anxiety symptoms and associated functional impairment in specific situations or as a state measure. Cronbach's alpha was .94 |
| Secondary | The Overall Depression Severity and Impairment Scale (ODSIS; Osma et al., 2022) | Pre-session assessment (sessions 2-10) | It is a five-item unidimensional scale designed to assess the severity of depressive symptoms and associated functional impairment as a state or in specific situations. Cronbach's alpha was .95 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07911111
GET https://conductscience.org/api/trials/v1/NCT07911111/registered